Search

You searched for "ROP"

1961 results found

OSA wine promotion open to all 100% Optical visitors

12 February 2024 | wine, giveaway, conferences, events, 100% Optical, 100% ophthalmology, OSA, promotion
The OSA is keen to ensure that visitors to 100% Optical engage with the broad spectrum of specialist suppliers at the three-day event, which runs from 24-26 February at Excel, London.

October meeting to announce major OSA news

7 October 2024 | optometry, optician, 100% Optical, 100% Ophthalmology, meetings, events, Conferences, Industry
A major development at the Optical Suppliers' Association (OSA), which will bring significant advances for eHealth interoperability, will be announced at the 16th October meeting in London. As the speed of change in optics advances at great pace, the OSA...
Ocular immunology and inflammation journal cover image.

Acute retinal necrosis: an Indian experience

1 August 2014 | | EYE - Pathology, EYE - Oncology
The authors of this retrospective study aimed to provide clinical outcomes in 62 eyes of 53 patients presenting with acute retinal necrosis. All eyes received intravenous acyclovir (10mg/kg tds) for 7-10 days followed by oral antiviral therapy (valaciclovir 1g tds...
Journal of Pediatric Ophthalmology & Strabismus cover image.

Dichoptic vs occlusion therapy outcomes for anisometropic amblyopia

1 March 2024 | | EYE - Paediatrics, EYE - Strabismus
The authors evaluated a binocular Tetris game for Android phones and compared its effectiveness, compliance and adverse events with part-time patching in children with anisometropic amblyopia. This was a prospective randomised study. Group 1 played the game for two hours...

OSA Insights to Market win praise from members

31 October 2023 | OSA, Meetings, Events, Market insight, Opticians, E-Health
OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.

Usefulness of gonioscopy to investigate cause of corneal oedema after cataract surgery

1 December 2021 | | EYE - Cornea, EYE - General
A 72-year-old man with ocular hypertension presented three months after routine right phacoemulsification and toric intraocular lens (IOL) implantation with a two-week history of an irritated right eye and a sudden deterioration in right vision. His preoperative spherical equivalence was...

Looking on the brightside: Lord David Blunkett

4 December 2025 | | EYE - General
“I can hear people smile” As a young adult in the 1980s and 1990s I gradually became more politically informed with occasional forays into BBC’s Question Time. In doing so, I learnt of the rise of politician David Blunkett, a...

The results of the last survey Oct21

1 October 2021 | | EYE - Cataract, EYE - Refractive, EYE - General
This edition’s survey questions moved away from the deep and ethically charged questions of the recent surveys and focussed on simple and straightforward issues. This is really where the surveys began in exploring the minor practice variations which we have...

Haag-Streit launches 5th ‘Slit Lamp Imaging Competition’

14 April 2023 | competition, Imaging, photography
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is delighted to announce the launch of the ‘Slit Lamp Imaging Competition 2023’.

Ombudsman responds to Letby verdict

21 August 2023 | Ombudsman, Lucy Letby, NHS
Parliamentary and Health Service Ombudsman, Rob Behrens, comments on the verdict in the trial of Lucy Letby.

Retina UK Annual Conference 2026

19 September 2026
Retina UK Annual Conference 2026

Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines

8 December 2023 | NuVision, Andy Hill, amniotic membranes, guidelines, AOP, optometrist, outpatient, dry eye, lens
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.